Reslerova M, Loutzenhiser R
Department of Pharmacology and Therapeutics, University of Calgary, Canada.
Circ Res. 1995 Dec;77(6):1114-20. doi: 10.1161/01.res.77.6.1114.
K+ channel openers (PCOs), such as pinacidil, elicit vasodilation primarily by hyperpolarization-induced inhibition of L-type Ca2+ channel activation. The physiological role of other mechanisms suggested to contribute to PCO-induced vasodilation is not well established. In the renal microcirculation, L-type Ca2+ channels play a prominent role in vasoconstriction of the afferent arteriole (AA) but are absent or physiologically silent in the efferent arteriole (EA). Thus, L-type Ca2+ channel-dependent and -independent mechanisms can readily be distinguished in this model. In the present study, we found that pinacidil potently inhibited Bay K 8644-induced AA vasoconstriction. Pinacidil also preferentially inhibited angiotensin II-induced AA vasoconstriction (approximately ninefold greater potency than EA). These results are consistent with an AA effect of pinacidil on L-type Ca2+ channel activation. Unexpectedly, 10 mumol/L pinacidil inhibited AA and EA responses to similar extents (84 +/- 10% and 71 +/- 9%, respectively). In both AAs and EAs, glibenclamide restored normal reactivity, indicating an involvement of the ATP-sensitive K+ channels. In the EA, however, pretreatment with diltiazem did not alter the effects of pinacidil. Nevertheless, 45 mmol/L KCl reversed the EA actions of pinacidil, indicating an essential requirement for a normal K+ gradient. These findings suggest that the EA actions of pinacidil involve alterations in membrane potential but not changes in L-type Ca2+ channel activity. Overall, our findings do support the premise that L-type Ca2+ channel modulation is involved in PCO-induced vasodilation in the renal microcirculation.(ABSTRACT TRUNCATED AT 250 WORDS)
钾离子通道开放剂(PCOs),如吡那地尔,主要通过超极化诱导的L型钙离子通道激活抑制作用来引起血管舒张。其他被认为有助于PCO诱导血管舒张的机制的生理作用尚未完全明确。在肾微循环中,L型钙离子通道在入球小动脉(AA)的血管收缩中起重要作用,但在出球小动脉(EA)中不存在或生理上处于静息状态。因此,在该模型中可以很容易地区分L型钙离子通道依赖性和非依赖性机制。在本研究中,我们发现吡那地尔能有效抑制Bay K 8644诱导的AA血管收缩。吡那地尔还优先抑制血管紧张素II诱导的AA血管收缩(效力比EA约大九倍)。这些结果与吡那地尔对AA上L型钙离子通道激活的作用一致。出乎意料的是,10 μmol/L吡那地尔对AA和EA反应的抑制程度相似(分别为84±10%和71±9%)。在AA和EA中,格列本脲均可恢复正常反应性,表明ATP敏感性钾离子通道参与其中。然而,在EA中,地尔硫䓬预处理并未改变吡那地尔的作用。尽管如此,45 mmol/L氯化钾可逆转吡那地尔对EA的作用,表明正常钾离子梯度是必需的。这些发现表明,吡那地尔对EA的作用涉及膜电位改变,但不涉及L型钙离子通道活性变化。总体而言,我们的发现确实支持L型钙离子通道调节参与肾微循环中PCO诱导血管舒张这一前提。(摘要截断于250字)